We are live on ! Find out more
BOUT icon

CapForce IBD Breakout Opportunities ETF

11 hedge funds and large institutions have $1.47M invested in CapForce IBD Breakout Opportunities ETF in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more capital invested

Capital invested by funds: $779K → $1.47M (+$693K)

38% more funds holding

Funds holding: 811 (+3)

9.55% more ownership

Funds ownership: 16.98%26.53% (+9.6%)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
11
Holders Change
+3
Holders Change %
+37.5%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
4
Closed
Calls
Puts
Net Calls
Net Calls Change

BOUT Hedge Fund Activity: Q2 2020 in Review

11 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD Breakout Opportunities ETF (BOUT) for Q2 2020, worth a combined $1.47M — up 89% from $779K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BOUT positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 4 trimmed.

The largest buyer was F3Logic, opening a new position worth an estimated $202K. The largest seller was Veracity Capital, cutting an estimated $33.8K.

  • 11 institutional investors held CapForce IBD Breakout Opportunities ETF (BOUT) as of Q2 2020, up from 8 in Q1 2020.
  • Funds reported $1.47M of CapForce IBD Breakout Opportunities ETF stock for Q2 2020, up 89% quarter-over-quarter.
  • 3 funds opened new CapForce IBD Breakout Opportunities ETF positions in Q2 2020 and 0 closed out, a net change of +3 holders.
  • The largest CapForce IBD Breakout Opportunities ETF buyer in Q2 2020 was F3Logic, an estimated $202K added.
  • The largest CapForce IBD Breakout Opportunities ETF seller in Q2 2020 was Veracity Capital, an estimated $33.8K sold.

Based on aggregated 13F filings for Q2 2020.